Recent Quotes

My Watchlist

Indicators

Achilles Therapeutics Plc (NQ: ACHL )

1.000 -0.020 (-1.96%)

Streaming Delayed Price Updated: 3:58 PM EDT, Oct 31, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	78,943
Open	1.000
Bid (Size)	0.9810 (85)
Ask (Size)	1.020 (94)
Prev. Close	1.020
Today's Range	0.9820 - 1.010
52wk Range	0.6300 - 1.760
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Achilles Therapeutics Shares Are Trading Higher: What You Need To Know

September 19, 2024

Shares of Achilles Therapeutics plc (NASDAQ: ACHL) are surging following a major strategic announcement from the company. The biotechnology firm revealed plans to discontinue its TIL-based cNeT program...

Via Benzinga

ACHL Stock Earnings: Achilles Therapeutics Meets EPS for Q2 2024

August 14, 2024

ACHL stock results show that Achilles Therapeutics met analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Performance

YTD	+14.68%	+14.68%
1 Month	N/A	N/A
3 Month	+24.63%	+24.63%
6 Month	+28.21%	+28.21%
1 Year	+19.05%	+19.05%

More News

Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines

May 22, 2024

From Achilles Therapeutics PLC

Via GlobeNewswire

ACHL Stock Earnings: Achilles Therapeutics Beats EPS for Q1 2024

May 08, 2024

Via InvestorPlace

Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

May 08, 2024

From Achilles Therapeutics PLC

Via GlobeNewswire

Achilles Therapeutics: Q1 Earnings Insights

May 10, 2023

Via Benzinga

Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results

April 04, 2024

Via Benzinga

Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

April 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session

April 04, 2024

Via Benzinga

Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings

April 04, 2024

Via Benzinga

ACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023

April 04, 2024

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session

April 04, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

April 04, 2024

Via InvestorPlace

Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights

April 04, 2024

From Achilles Therapeutics PLC

Via GlobeNewswire

Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning

April 04, 2024

From Achilles Therapeutics PLC

Via GlobeNewswire

Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference

February 05, 2024

From Achilles Therapeutics PLC

Via GlobeNewswire

Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction

December 18, 2023

From Achilles Therapeutics PLC

Via GlobeNewswire

Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights

November 13, 2023

From Achilles Therapeutics PLC

Via GlobeNewswire

10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis

October 23, 2023

Via ACCESSWIRE

Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

September 20, 2023

Via Investor Brand Network

Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

September 20, 2023

Via FinancialNewsMedia

12 Health Care Stocks Moving In Thursday's After-Market Session

September 07, 2023

Via Benzinga

Achilles Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

August 04, 2023

From Achilles Therapeutics PLC

Via GlobeNewswire

Achilles Therapeutics to Present at Upcoming Conferences

June 12, 2023

From Achilles Therapeutics PLC

Via GlobeNewswire

3 Stocks With 1,000% Upside Potential

May 21, 2023

Via InvestorPlace

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.